Investigation into death of baby boy at Aberdeen children's hospital launched
The death will be investigated as part of a Fatal Accident Inquiry (FAI) by the procurator fiscal.
Michael Wilson was born on August 11 2021 at Aberdeen Maternity Hospital. He died two months later at Royal Aberdeen Children's Hospital on October 15.
A preliminary hearing into the baby's death is due to begin on September 11 at Aberdeen Sheriff Court.
According to the Lord Advocate, Michael's death raises 'serious public concerns'.
The FAI will determine the cause of death, the circumstances in which the death occurred. It will also establish what, if any, reasonable precautions could have been taken.
And it will examine if future actions could help minimise deaths in similar circumstances.
FAIs are 'inquisitorial' and used to establish facts and not assign blame.
This inquiry will explore the circumstances of Michael's death.
It will particularly focus on the understanding and appreciation of the risk and complexities of his condition along with information sharing between health boards and with family members.
It will also consider if NHS Grampian's reviews identified sufficient and appropriate measures to prevent the occurrence of any similar deaths occurring in the future.
Procurator Fiscal Andy Shanks, who leads on death investigations, said: 'The Lord Advocate considers that the death of Michael Wilson occurred in circumstances giving rise to serious public concern, and as such, a discretionary Fatal Accident Inquiry should be held.
'The lodging of the First Notice enables FAI proceedings to commence under the direction of the Sheriff.
'Michael's family will continue to be kept informed of significant developments as court proceedings progress.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
8 hours ago
- Daily Record
Doggy 'Mounjaro' could be the next solution for treating pudgy pets
A new form of pet health care may be on the horizon as scientists sniff around weight loss drugs for dogs. With many people wanting to lose weight across the globe, drugs such as Mounjaro have become a household name. Helping people manage their weight, those on a health kick along with the medication are able to learn how to eat healthier and have a better lifestyle. Following on from their apparent success, researchers are now turning their view to a different form of clientele that they believe may be in need of a detox. While many of us see our four-legged friends as perfect no matter how they look, it turns out that up to 60 per cent of dogs in the UK are classed as obese or overweight. With this startling stat, some scientists feel like there is room in the market for weight loss drugs for dogs. And it may not be too far on the horizon. San Francisco-based bio-phama company Okava have set their sites on the new frontier of pet health and are planning to run trials of a drug that will mimic the effects of medications like Ozempic. The end goal is to create an implant version of the drug for dogs, which will last for six months at a time. Ozempic is not marketed as a weight loss drug but one to prescribed to type 2 diabetes patients to help manage their condition by controlling blood sugar levels alongside other medications and lifestyle changes. However, it has gained popularity and attention for its potential role in weight loss, which can be a side effect of the drug's appetite-controlling abilities. With hopes of have the canine weight loss drug available as early as 2028 or 2029, the US company estimates the current market for this product could be worth up to $10billion. In terms of the human version, the drugs mimic a natural hormone called GLP-1 which regulates blood sugar and appetite. In Mounjaro is active ingredient is called tirzepatide, whereas Ozempic uses semaglutide. The ultimate goal of these ingredients is to leave users feeling fuller for longer, which will end up reducing their overall food intake. As scientists try to mimic this hormone for dogs, it is hoped that the drug will help reduce the begging behaviour of our furry pals, which many owners find hard to resist. However, researchers will need to make sure they find the right balance with the drug as a lack of appetite in our canine companions is normally associated with being unwell. This isn't the first weight loss drug that has been created for pets, as Slentrol was released in 2007. However, this creation didn't end up selling well, partly due to owners believing their pets seemed ill while on the medication. However, Okava's chief executive Michael Klotsman hopes that any behavioural changes in dogs while using their drug will be quite different. The planned implant by Okava has been named OKV-119 and will contain a GLP-1 mimic called exenatide. Michael told The Guardian: "What owners should expect to see is their pet eating appropriate portions without the previous food obsession – they'll still eat regularly and show interest in meals, just without the excessive begging, scavenging or gulping behaviour." However, not everyone is fully on board with the idea. Many vets are instead advising that overweight dogs, in most cases, are able to lose the extra pounds through more exercise and a restricted diet Caroline Allen, chief veterinary officer at the RSPCA told The Independent: "A healthy diet and exercise is the best way to keep our pets happy and well but we understand that owners can sometimes struggle to manage their pets' weight. "There is currently little information about proposed weight-loss implants or vaccinations for animals, and owners shouldn't rely on them becoming available. "Before resorting to these sorts of interventions, owners should seek help from their vet about how to reduce their pet's weight with a good diet and providing lots of opportunities to exercise and play in ways that their pet will enjoy." She added: "It may be that weight loss jabs or implants may have a role to play in future in very limited circumstances where animals are clinically unwell, but the best thing we can do is set healthy habits from the start so our pets can live the best life possible." Join the Daily Record WhatsApp community!
Press and Journal
16 hours ago
- Press and Journal
Aberdeen man thriving three years after care home's failings left him facing needless 'end of life' care
Recent failings at a troubled Aberdeen care home have stirred up painful memories for a former resident's family, whose loved one was hospitalised for severe malnourishment. Wendy Sutton spoke candidly about her family's ordeal after her brother, Michael Yeoman, was placed in Hamewith Lodge in Northfield back in 2022. She told The Press and Journal his care left him so poorly that a visiting nurse believed he was in his final days. The worried medical professional is even said to have prescribed end of life medication to ease his pain. Only when he was hospitalised did the care home's failings become clear. He made a significant recovery after being moved from Hamewith Lodge and, in new accommodation, is 'thriving' three years on from his ordeal. Wendy is clear that the home badly failed her brother, with key issues including poor nutrition and medication mismanagement — complaints that were upheld by the Care Inspectorate. She has come forward to speak out after a 2025 report outlined continued failings at Hamewith. For Wendy the issues raised by inspectors are eerily similar to those made by she and her family during her brother's time there. It was back in February 2022 that Michael, aged 67, was moved from his specialist home into Hamewith Lodge. He suffers from severe mental disabilities, with the family referring to him as 'Peter Pan' as he has the mental age of a five-year-old. He'd been in the care home just two months when it became clear his health was declining rapidly, prompting the family to demand help. A Covid outbreak at the home had forced the cancellation of family visits. But they continued to interact with him over video and Wendy could see a difference in his appearance. 'We noticed on a number of occasions, with each and every FaceTime, that Michael was deteriorating,' she said. 'He was rocking back and forth in his chair. He wasn't communicating very well. And he had black eyes and bruising on his body.' According to Wendy, the staff said her brother's appearance was simply down to Covid. But within six weeks he had lost 10kg in weight. Michael's brother Brian tried to visit him, but was told by staff that he was 'fine'. Undeterred, Brian turned up unannounced, creating what the family said was 'visible panic' among the staff. And in fact, by the end of the day, staff had attempted to administer end of life care – a move that confounded his siblings. Wendy said: 'They told us he was 'end of life' but we couldn't understand why because he had recovered from Covid, and his vitals and blood pressure were good. 'We were told we couldn't sit in with Michael because he was end of life. He was prescribed end of life drugs. 'We demanded that Michael be taken to hospital but they didn't want that. 'They said he was comfortable where he was and we were advised to leave him. 'We fought to get him into the hospital. 'At the hospital we were told that he was suffering from malnutrition and severe dehydration and they didn't know if he would pull through. 'Michael would have died if we hadn't intervened.' A spokesperson for HC-One, which operates Hamewith Lodge, told The Press and Journal: 'Mr Yeoman sadly experienced a rapid decline in his health in May 2022, which prompted colleagues to contact his GP services for additional medical advice. 'Following a consultation with an NHS advanced nurse practitioner, Mr Yeoman was placed on 'End of Life Care' and was moved to hospital soon after. 'This decision was not made by colleagues at the home and a subsequent hearing by the Nursing and Midwifery Council found no wrongdoing.' Despite that, Wendy lodged five specific complaints with the Care Inspectorate regarding Michael's situation. All were upheld. In documents made available to The P&J, the Care Inspectorate found: For Wendy, reading the 2025 report into Hamewith Lodge left her 'horrified'. She said: 'It was the same situation as before. 'The care inspector's recommendations are exactly what they said to us in 2022. 'It's now 2025 and I just think someone is going to die in that home before something is actually done.' One complaint Wendy made was that Michael was given improper doses of medication. This was echoed by inspectors in the 2025 report. She said: 'I couldn't believe how many times we had put in concerns about certain things over the few weeks that Michael was there. 'It was practically on a daily basis that there were always issues.' An HC-One spokesperson added: 'We take the feedback and findings from the Care Inspectorate very seriously. 'We acknowledge that the standard of care for Mr Yeoman fell below the level we as an organisation set ourselves and our residents expect. 'We apologise for the upset and distress caused to Mr Yeoman and want to reassure his family that everyone at the home is continually committed to raising the standards of care to an appropriate level.' Hamewith Lodge made improvements following the problems in 2022, achieving a 'very good' rating in a 2024 report. The report noted that during that time a new management team had been installed. Hamewith Lodge was also praised for being 'clean, tidy and clutter free'. However, in the nine months since that report, there has once again been a decline in standards. Following his hospital admission, Michael remained in a hospital bed for weeks as he recovered. He was then offered a chance to live at Cowdray Club Care Home, where he remains to this day. Wendy said: 'He has improved greatly since being at Cowdray Club. 'It's a wonderful end to the story, because it could have had a very different ending.'
Times
16 hours ago
- Times
Rude patients, anxiety and stab vests: my life as a NHS doctor
I have been a doctor since 2012. Now, as a registrar, I specialise in rheumatology. Becoming a rheumatologist requires humility. Seriously, I am the Michael Jordan of modesty. It's not really dinner party medicine on a par with surgery or cardiology, is it? Every blank look when you tell people your speciality is another serving of that ego-choking humble pie. Broadly speaking, our remit is inflammatory diseases caused by a misbehaving immune system — usually affecting the joints, but often attacking many other organs. Then there is the other half of my job — working in acute general medicine, managing the unsorted wash of medical patients coming into the hospital. There is a romantic part of me that clings to the idea that medicine in A&E is a noble tradition that helps keep specialists sharp and in touch with the wider hospital.
